The MDR program analysis (Fig. 2) did not identify any statistically significant association between cancer and the KRAS-LCS6 and SLC23A2-05 polymorphisms (ratio, 0.7174; testing balanced accuracy, 0.5157; P=0.4090). The gene discussed is SLC23A2; the disease is cancer.